Oxford University’s coronavirus vaccine opens for clinical trial on humans
ChAdOx1 nCoV-19, the COVID-19 vaccine developed by Oxford, is based on an adenovirus vaccine vector and the SARS-CoV-2 spike protein.
from The Hindu - Science https://ift.tt/2WLGD2N
from The Hindu - Science https://ift.tt/2WLGD2N
Comments
Post a Comment